Risk of depressive disorder among patients with herpes zoster: A nationwide population-based prospective study

Psychosomatic Medicine

Volumn 76, Issue 4, 2014, Pages 285-291

  Chen, Mu Hong ^a,b,c   Wei, Han Ting ^a,b   Su, Tung Ping ^a,b   Li, Cheng Ta ^a,b   Lin, Wei Chen ^a,b   Chang, Wen Han ^a,b   Chen, Tzeng Ji ^a,b   Bai, Ya Mei ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Department of Psychiatry ^*  (Taiwan)

Author keywords

Comorbidity; Depression; Herpes zoster

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; CHRONIC DISEASE; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; EPIDEMIOLOGY; HEALTH INSURANCE; STATISTICS AND NUMERICAL DATA; TAIWAN;

CHRONIC DISEASE; COMORBIDITY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; EPIDEMIOLOGIC METHODS; FEMALE; HERPES ZOSTER; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; TAIWAN;

EID: 84900872047     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000051     Document Type: Article

References (45)

1. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002;347:340-6.
2. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007;356:1338-43.
3. Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001;127:305-14.
4. Gershon AA, Perkin RT. Herpes zoster. N Engl J Med 2000;343:222; author reply 3.
5. Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008. Epidemiol Infect 2012;140:1131-40.
6. Lin YH, Huang LM, Chang IS, Tsai FY, Lu CY, Shao PL. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine 2010;28: 1217-20.
7. Dean B, Tawadros N, Scarr E, Gibbons AS. Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. J Affect Disord 2010;120:245-8.
8. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012;36:764-85.
9. Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-Alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-Analysis and meta-regression. J Affect Disord 2012;139:230-9.
10. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:664-75.
11. Maes M, Mihaylova I, Kubera M, Ringel K. Activation of cell-mediated immunity in depression: Association with inflammation,melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuropsychopharmacol Biol Psychiatry 2012;36:169-75.
12. Maes M, Ringel K, Kubera M, Berk M, Rybakowski J. Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord 2012;136:386-92.
13. Irwin M, Costlow C,Williams H, Artin KH, Chan CY, Stinson DL. Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis 1998;178(Suppl 1):S104-8.
14. Irwin MR, Levin MJ, Carrillo C, Olmstead R, Lucko A, Lang N. Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav Immun 2011;25:759-66.
15. Irwin MR, Levin MJ, Laudenslager ML, Olmstead R, Lucko A, Lang N. Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications. Clin Infect Dis 2013;56:1085-93.
16. Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: A prospective study. CMAJ 2010;182:1731-6.
17. Clark MR, Heinberg LJ, Haythornthwaite JA, Quatrano-Piacentini AL, Pappagallo M, Raja SN. Psychiatric symptoms and distress differ between patients with postherpetic neuralgia and peripheral vestibular disease. J Psychosom Res 2000;48:51-7.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-83.
19. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004;4:26-33.
20. Palagini L, Mosca M, Tani C, Gemignani A, Mauri M, Bombardieri S. Depression and systemic lupus erythematosus: A systematic review. Lupus 2013;22:409-16.
21. Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: Patient-reported outcomes in six European countries. Z Gesundh Wiss 2012;20:441-51.
22. Dworkin RH, Gnann Jr. J.W., Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain 2008;9(1 Suppl 1):S37-44.
23. Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: Prevention and management. Am Fam Physician 2011;83:1432-7.
24. Nalamachu S, Morley-Forster P. Diagnosing and managing postherpetic neuralgia. Drugs Aging 2012;29:863-9.
25. Thakur R, Philip AG. Chronic pain perspectives: Treating herpes zoster and postherpetic neuralgia: An evidence-based approach. J Fam Pract 2012; 61(Suppl 9):S9-15.
26. Johnson RW, Bouhassira D, Kassianos G, Leplege A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010;8:37.
27. Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004;39:342-8.
28. Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 2007;23:490-6.
29. van Seventer R, Sadosky A, Lucero M, Dukes E. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing 2006;35:132-7.
30. Volpi A, Gatti A, Pica F, Bellino S, Marsella LT, Sabato AF. Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol 2008;80: 1646-52.
31. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A. The relationship of depression and stressors to immunological assays: A metaanalytic review. Brain Behav Immun 2001;15:199-226.
32. Irwin MR. Human psychoneuroimmunology: 20 years of discovery. Brain Behav Immun 2008;22:129-39.
33. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 2007;21:374-83.
34. Miller AH. Depression and immunity: A role for T cells? Brain Behav Immun 2010;24:1-8.
35. Grinde B. Herpesviruses: Latency and reactivationVviral strategies and host response. J Oral Microbiol 2013;5. doi: 10.3402/jom.v5i0.22766.
36. Elwing JE, Lustman PJ, Wang HL, Clouse RE. Depression, anxiety, and nonalcoholic steatohepatitis. Psychosom Med 2006;68:563-9.
37. Weinstein AA, Kallman Price J, Stepanova M, Poms LW, Fang Y, Moon J. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 2011;52:127-32.
38. Toh BH, Roberts-Thomson IC, Mathews JD, Whittingham S, Mackay IR. Depression of cell-mediated immunity in old age and the immunopathic diseases, lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol 1973;14:193-202.
39. Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpeszoster attack: A population-based follow-up study. Stroke 2009; 40:3443-8.
40. Volpi A. Severe complications of herpes zoster. Herpes 2007;14(Suppl 2):35-9.
41. Altieri M, Maestrini I, Mercurio A, Troisi P, Sgarlata E, Rea V. Depression after minor stroke: Prevalence and predictors. Eur J Neurol 2012; 19:517-21.
42. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections of the nervous system: Clinical and pathologic correlates. Arch Pathol Lab Med 2001;125:770-80.
43. Gilden DH. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sci 2002;195:99-101.
44. Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: Mechanisms linking vascular disease with depression. Mol Psychiatry 2013;18:963-74.
45. Vaishnavi S, Taylor WD. Neuroimaging in late-life depression. Int Rev Psychiatry 2006;18:443-51.